Wegovy and Achy Legs: What You Should Know

What trial data and the prescribing information actually record

The STEP 1 trial (68 weeks, semaglutide 2.4mg versus placebo, published in the New England Journal of Medicine) remains the main evidence base for Wegovy's side-effect profile. Gastrointestinal effects dominated: nausea, diarrhoea, vomiting and constipation were the most frequently reported adverse events. Musculoskeletal complaints, including leg aches and myalgia, appeared at lower rates and were not among the reactions flagged for particular attention in the trial's safety reporting. If you want to understand whether Wegovy causes leg aches and what the evidence actually shows, that question gets a thorough answer including what the trial data recorded and what remains uncertain. The Wegovy Patient Information Leaflet, held on the Electronic Medicines Compendium, lists the full frequency breakdown; checking it directly gives you the most precise picture of what was recorded in studies. What the evidence does establish clearly is that most side effects peak early (around the time a new dose starts) and settle for most people within a couple of weeks.

If your legs have been aching since you moved to a higher dose, the timing is significant. Prescribers see this pattern: discomfort that tracks dose changes, then fades. That does not make it trivial, but it does help place it.

Why dehydration and reduced intake deserve more attention than they get

Semaglutide slows gastric emptying and reduces appetite markedly. For many people that also means drinking less, particularly when nausea makes the idea of fluids unappealing. Inadequate fluid intake is a well-recognised contributor to muscle cramps and leg heaviness, and it is one of the more correctable causes of achiness on this treatment. The NHS England guidance on weight-management injections specifically flags dehydration from severe gastrointestinal illness as a risk requiring clinical attention, because prolonged under-hydration can affect kidney function beyond just making your legs feel like concrete.

Protein intake matters here too. A sharply reduced calorie load (especially one that is low in protein) can lead to muscle loss alongside fat loss, and muscles that are losing mass can ache. Keeping protein adequate, staying active (even gently), and drinking consistently through the day are practical steps worth discussing with whoever is overseeing your care. None of this is specific medical advice for your situation; a dietitian or your prescriber is the right person to tailor it.

One thing our prescribers hear fairly regularly: patients who started treatment mid-month and then found a bank holiday or a late delivery interrupted their routine. If you are sourcing Wegovy through a regulated service and timing matters to you, building a small buffer into your order schedule helps avoid gaps that can themselves affect how you feel.

Leg symptoms that need medical attention promptly

Most aching in the legs during Wegovy treatment is diffuse, bilateral and tied to the pattern described above, it waxes with dose changes and eases with time, hydration and rest. There are symptoms, though, that sit outside this picture and should not wait for your next routine review.

Swelling in one leg, accompanied by redness, warmth and pain that is worse on standing or walking, can be a sign of deep vein thrombosis. Calf pain that follows a period of reduced mobility is similarly worth taking seriously. These presentations are not known complications of semaglutide specifically, but they can occur in anyone, and weight-management treatment is sometimes accompanied by lifestyle changes (long rest periods after illness, for example) that can increase general risk. The MHRA Yellow Card scheme exists precisely so that unexpected symptom patterns in people on new medicines get reported; if you experience something that feels out of the ordinary, reporting it there is a constructive step alongside seeking clinical advice.

Explore the broader question of whether Wegovy causes general achiness if your discomfort extends beyond the legs, or read about leg pain specifically for more clinical context. For the mechanics of injecting into the thigh, including how technique affects local soreness, that page covers the detail.

When to loop in your prescriber, and what to tell them

A prescriber assessing leg discomfort on Wegovy will want to know: when the aching started relative to your last dose or dose change, whether it is in both legs or one, whether there is any swelling or skin change, how your fluid intake has been, and whether it is getting better or worse over time. That information shapes whether this is an expected adjustment effect or something needing investigation.

At nume, a clinician (not an automated system) reads your notes and any aftercare messages the same day. If you are on treatment with us and something feels off, our aftercare team is available seven days a week. For anyone who has not yet started and is weighing up the full side-effect picture before deciding, our weight-loss treatment overview explains how clinical assessment works and what to expect. The Wegovy information page covers the treatment itself in more detail, including how it compares to other licensed options.

Starting a free consultation means a GPhC-registered prescriber looks at your full picture (history, current medicines, and any concerns like this one) before anything is prescribed. There is no pressure, and no treatment begins until a clinician is satisfied it is right for you. Start your free consultation if you would like that assessment.